Entyvio® (vedolizumab)
for Crohn’s Disease

Entyvio (vedolizumab) is a biologic treatment for ulcerative colitis (UC) and Crohn’s disease (CD). It helps reduce inflammation, improve symptoms, achieve remission, and decrease steroid use. As a selective immunosuppressant, Entyvio prevents excess white blood cells from entering the gut, reducing immune system overactivity and controlling inflammation to prevent damage.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Crohn’s Disease - CD